Covered recipient · General Payments record
REBECCA C RAMDHAN
Allopathic & Osteopathic Physicians Pediatrics Pediatric Hematology-Oncology
General Payments · PY2022–2024
$2,210.55
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,124.61 | 5 |
| Food and Beverage | $914.02 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CSL Behring | $1,802.20 | 20 |
| PFIZER INC. | $97.20 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.64 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $33.21 | 2 |
| GENZYME CORPORATION | $19.60 | 1 |
| Alexion Pharmaceuticals, Inc. | $19.17 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.00 | 1 |
| Novo Nordisk AS | $16.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $19.17 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110511282 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $17.00 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086135461 | CMS |
| CSL Behring | $110.11 | 04/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134625499 | CMS |
| CSL Behring | $76.80 | 04/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134625501 | CMS |
| CSL Behring | $23.77 | 04/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134625503 | CMS |
| CSL Behring | $67.67 | 04/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134625505 | CMS |
| CSL Behring | $413.20 | 04/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1134625507 | CMS |
| CSL Behring | $32.86 | 04/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1134625509 | CMS |
| CSL Behring | $537.70 | 04/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1134625511 | CMS |
| CSL Behring | $46.31 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134625513 | CMS |
| CSL Behring | $120.60 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134625515 | CMS |
| CSL Behring | $25.28 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134625517 | CMS |
| CSL Behring | $10.78 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134625519 | CMS |
| CSL Behring | $8.46 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134625521 | CMS |
| CSL Behring | $109.09 | 04/29/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1134625523 | CMS |
| CSL Behring | $62.21 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134625525 | CMS |
| CSL Behring | $72.75 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134625527 | CMS |
| CSL Behring | $22.63 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134625529 | CMS |
| CSL Behring | $9.11 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134625531 | CMS |
| CSL Behring | $13.96 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134625533 | CMS |
| CSL Behring | $7.15 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134625535 | CMS |
| CSL Behring | $31.76 | 05/15/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1134625537 | CMS |
| GENZYME CORPORATION | $19.60 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139835750 | CMS |
| Novartis Pharmaceuticals Corporation | $14.48 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087298027 | CMS |
| Novartis Pharmaceuticals Corporation | $18.73 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087298039 | CMS |
| Novo Nordisk Inc | $16.61 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108580471 | CMS |
| PFIZER INC. | $97.20 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131605664 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.64 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137658773 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.